Departments of Internal Medicine and Pediatrics, Center for Primary Care, University of Rochester, Rochester, New York, USA.
Department of Pharmacy Practice and Administration, Wegman's School of Pharmacy St. John Fisher College, Rochester, New York, USA.
Am J Hypertens. 2018 Feb 9;31(3):340-345. doi: 10.1093/ajh/hpx200.
Medication adherence is crucial to effective chronic disease management, yet little is known about the influence of the patient-provider interaction on medication adherence to hypertensive regimens. We aimed to examine the association between the patient's experience with care and medication adherence.
We collected 2,128 surveys over 4 years from a convenience sample of hypertensive patients seeking care at three urban safety-net practices in upstate New York. The survey collected adherence measures using the Morisky Medication Adherence Scale (MMAS-8) and patient experience measures. We used regression models to adjust for age, gender, race/ethnicity, self-reported health status, and clustering by patients. The primary outcome was reporting of medium-to-high adherence (MMAS ≥ 6) vs. low adherence.
A total of 62.5% of respondents reported medium-to-high medication adherence. The concern the provider demonstrated for patient questions or worries (adjusted odds ratio [AOR] 1.4; 95% confidence interval [CI] 1.1-1.7), provider efforts to include the patient in decisions (AOR 1.5; 95% CI 1.8-1.9), information given (AOR 1.3; 95% CI 1.0-1.6), and the overall rating of care received (AOR 1.4; 95% CI 1.1-1.8) were associated with higher medication adherence. The amount of time the provider spent was not associated with medication adherence (AOR 1.2; 95% CI 0.9-1.4). Medium-to-high medication adherence was in turn associated with increased hypertension control rates.
Overall, better experiences with care were associated with higher adherence to hypertension regimens. However, the amount of time the provider spent with the patient was not statistically associated with medication adherence, suggesting that the quality of communication may be more important than the absolute quantity of time.
药物依从性对于有效管理慢性疾病至关重要,但对于医患互动对高血压治疗方案的药物依从性的影响知之甚少。我们旨在研究患者对护理的体验与药物依从性之间的关联。
我们在纽约州北部的三家城市医疗保障机构中,从方便抽样的高血压患者中收集了 4 年来的 2128 份调查问卷。该调查采用 Morisky 药物依从性量表(MMAS-8)和患者体验量表来收集药物依从性的衡量标准。我们使用回归模型来调整年龄、性别、种族/民族、自我报告的健康状况和患者聚类的影响。主要结果是报告中高度和中度药物依从性(MMAS≥6)与低度药物依从性的比较。
共有 62.5%的受访者报告了中高度的药物依从性。医生对患者问题或担忧的关注程度(调整后的优势比[OR]为 1.4;95%置信区间[CI]为 1.1-1.7)、医生努力让患者参与决策的程度(OR 为 1.5;95% CI 为 1.8-1.9)、提供的信息(OR 为 1.3;95% CI 为 1.0-1.6)以及患者对护理的总体评价(OR 为 1.4;95% CI 为 1.1-1.8)与更高的药物依从性相关。医生花费的时间与药物依从性无关(OR 为 1.2;95% CI 为 0.9-1.4)。中高度的药物依从性与高血压控制率的提高有关。
总的来说,更好的护理体验与高血压治疗方案的更高药物依从性相关。然而,医生与患者相处的时间与药物依从性没有统计学上的关联,这表明沟通质量可能比绝对时间更重要。